Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trial
Punitha Sivanandam, Ayesa Syenina, Yvonne FZ Chan, Dorothy HL Ng, Esther S Gan, Jia Xin Yee, Christine YL Tham, Hwee Cheng Tan, Eugenia Z Ong, Eng Eong Ooi, Shirin Kalimuddin · 2026
Read Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trial by Punitha Sivanandam, Ayesa Syenina, Yvonne FZ Chan, Dorothy HL Ng, Esther S Gan, Jia Xin Yee, Christine YL Tham, Hwee Cheng Tan, Eugenia Z Ong, Eng Eong Ooi, Shirin Kalimuddin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13478625.txt.
Description
Punitha Sivanandam and colleagues test whether a common antibiotic can prime antiviral defences in humans. Their randomised trial from twenty twenty-six was run in Singapore. In animal work, these drugs switched on interferon defence genes. Whether body-wide dosing does the same in people was unknown.
Thirty-two healthy adults received gentamicin or a placebo by infusion. All were then given a weakened yellow fever vaccine virus. Blood virus levels formed the main outcome measure. Immune gene activity and antibody levels were also tracked. The antibiotic did activate immune signals, per the study title findings. Yet viral control did not improve enough to matter. Immune activation alone proved insufficient here.
Catalog record
| CREATOR | Punitha Sivanandam, Ayesa Syenina, Yvonne FZ Chan, Dorothy HL Ng, Esther S Gan, Jia Xin Yee, Christine YL Tham, Hwee Cheng Tan, Eugenia Z Ong, Eng Eong Ooi, Shirin Kalimuddin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |